Korean name: Bifidobacterium breve B-3 프로바이오틱스(제2023-2호). This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
(국문) 체지방 감소에 도움을 줄 수 있음
(영문) May help to reduce body fat
Precautions (Korean original)
(1) 영·유아, 어린이, 임산부 및 수유부는 섭취에 주의할 것
(2) 특정질환(알레르기 체질 등)이 있는 분은 섭취에 주의할 것
(3) 질환이 있거나 의약품 복용 시 전문가와 상담할 것
(4) 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것
(5) 어린이가 함부로 섭취하지 않도록 일일섭취량 방법을 지도할 것
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.